Latest in FAIM
iiiiiiiii
December 1, 2022
at December 1, 2022Published by FDA Updates
AI programs have been developed to scan lung disease, treat OSA, and perform remote patient monitoring...
Do you like it?
December 1, 2022
at December 1, 2022Published by News
The FDA approved apps to improve mental health, scan for diabetic retinopathy and develop drugs more efficiently with AI, to name a few...
Do you like it?
December 1, 2022
December 1, 2022
at December 1, 2022Published by Editor’s Pick
ConcertAI is a global pioneer for life science businesses and healthcare professionals in precision oncology, combining AI technology, real-world data...
Do you like it?
December 1, 2022
at December 1, 2022Published by AI History
The years 1974-1976 witnessed the work of many scientists revolutionizing AI from Biomedical informatics to Natural language processing...
Do you like it?
December 1, 2022
at December 1, 2022Published by Journal Club
This helpful tool can achieve these goals, and more comprehensive mobility data can be discovered using this innovative CVT...
Do you like it?
December 1, 2022
at December 1, 2022Published by Wearable Devices
The Q-collar is used by athletes and the military to reduce the adverse outcome of concussions secondary to head impact trauma...
Do you like it?
December 1, 2022
November 1, 2022
at November 1, 2022Published by Editor’s Pick
Viz.ai coordinates stroke care, reducing systematic gaps between patients and life-saving treatments with their groundbreaking AI software...
Do you like it?
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.